This Month's Features
A Patient-Centered Approach to Management of Metabolic Syndrome
With Novel GLP-1 Therapies
Originally presented April 6, 2011, at the San Diego Convention Center, in California, this educational activity focuses on the latest clinical data on cardiovascular risk factors and long-acting GLP-1 therapies and emphasizes early, aggressive management of comorbid risk factors and metabolic conditions. This event was not part of the official Internal Medicine 2011 Education Program.
Access the symposium
CME KOL Video Debate
Four multidisciplinary key opinion leaders debate cutting-edge issues in 6 videos, each highlighting a different aspect of hypogonadism management. Martin M. Miner, MD (primary care), serves as Chairperson, and the faculty are Adrian S. Dobs, MD, MHS (endocrinology); Robert A. Kloner, MD, PhD (cardiology); and Abraham Morgentaler, MD (urology).
Watch the videos
CME Newsletter
Awareness is growing that osteoporosis, long considered a women's health issue, significantly affects men. Gaining a fuller understanding of the epidemiology, pathogenesis, diagnosis, and treatment of osteoporosis in men and how it relates to comorbidities, such as hypogonadism, is increasingly important. It is imperative for clinicians to recognize male osteoporosis as a serious health concern and develop a protocol for how to best manage it. This issue of
TU Times examines the relationship between bone health and hypogonadism. The feature article by Adrian S. Dobs, MD, MHS, describes our current understanding of osteoporosis and examines how treating hypogonadism may improve both conditions and lead to better overall health. In the interview, John E. Morley, MB, BCh, explains how he manages concomitant osteoporosis and hypogonadism for his patients.
Read the issue
